ATE52516T1 - Technetiumchelate fuer die bestimmung der nierenfunktion. - Google Patents

Technetiumchelate fuer die bestimmung der nierenfunktion.

Info

Publication number
ATE52516T1
ATE52516T1 AT87200876T AT87200876T ATE52516T1 AT E52516 T1 ATE52516 T1 AT E52516T1 AT 87200876 T AT87200876 T AT 87200876T AT 87200876 T AT87200876 T AT 87200876T AT E52516 T1 ATE52516 T1 AT E52516T1
Authority
AT
Austria
Prior art keywords
group
chelate
atoms
technetium
atom
Prior art date
Application number
AT87200876T
Other languages
English (en)
Inventor
Alfons M Prof Dr Verbruggen
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of ATE52516T1 publication Critical patent/ATE52516T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87200876T 1986-05-28 1987-05-13 Technetiumchelate fuer die bestimmung der nierenfunktion. ATE52516T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8601369 1986-05-28
EP87200876A EP0250013B1 (de) 1986-05-28 1987-05-13 Technetiumchelate für die Bestimmung der Nierenfunktion

Publications (1)

Publication Number Publication Date
ATE52516T1 true ATE52516T1 (de) 1990-05-15

Family

ID=19848082

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87200876T ATE52516T1 (de) 1986-05-28 1987-05-13 Technetiumchelate fuer die bestimmung der nierenfunktion.

Country Status (8)

Country Link
US (1) US4849511A (de)
EP (1) EP0250013B1 (de)
JP (1) JPS62289596A (de)
AT (1) ATE52516T1 (de)
AU (1) AU611854B2 (de)
CA (1) CA1316296C (de)
DE (1) DE3762624D1 (de)
ES (1) ES2017088B3 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980147A (en) * 1984-06-25 1990-12-25 University Of Utah Research Foundation Radiolabeled technetium chelates for use in renal function determinations
US5393512A (en) * 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
US4965392A (en) * 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
US5091514A (en) * 1987-03-26 1992-02-25 Neorx Corporation Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
US4846187A (en) * 1987-12-01 1989-07-11 The Center For Molecular Medicine And Immunology Dual isotope scintigraphic image enhancement
US5071636A (en) * 1987-12-29 1991-12-10 Nihon Medi-Physics Co., Ltd. Chelating compounds and their use
US5202451A (en) * 1988-02-17 1993-04-13 Neorx Corporation Anchimeric radiometal chelating compounds
US5218128A (en) * 1988-06-15 1993-06-08 Centocor, Inc. Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
US5171563A (en) * 1988-09-30 1992-12-15 Neorx Corporation Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
DE68919366T2 (de) * 1988-09-30 1995-05-18 Neorx Corp Spaltbare linker zur reduzierung der akkumulierung von immunokonjugaten in nicht-zielorganen.
US4925650A (en) * 1988-11-16 1990-05-15 Mallinckrodt, Inc. Technetium -99m complex for examining the renal function
US5164176A (en) * 1989-06-16 1992-11-17 Neorx Corporation Radionuclide metal chelates for the radiolabeling of proteins
US5250666A (en) * 1989-06-16 1993-10-05 Neorx Corporation Radionuclide metal chelates for the radiolabeling of proteins
US5759515A (en) * 1989-08-09 1998-06-02 Rhomed Incorporated Polyvalent peptide pharmaceutical applications
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US5700444A (en) * 1992-02-20 1997-12-23 Rhomed Incorporated Chemotactic peptide pharmaceutical applications
US5112953A (en) * 1989-12-29 1992-05-12 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use
US5175257A (en) * 1989-12-29 1992-12-29 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use
ATE170757T1 (de) * 1990-04-17 1998-09-15 Mallinckrodt Medical Inc Methode und reagentien um technetium-99m-komplexe herzustellen
US5684137A (en) * 1990-09-28 1997-11-04 Neorx Corporation S3 N chelating compounds for the radiolabeling of ligands, anti-ligands or other proteins
US5252721A (en) * 1990-09-28 1993-10-12 Neorx Corporation S3 N chelating compounds
US5037631A (en) * 1990-10-29 1991-08-06 Mallinckrodt Medical, Inc. Technetium-99M complex for examinating the renal function
US5116598A (en) * 1990-10-29 1992-05-26 Mallinckrodt Medical, Inc. N4 technetium-99 m complexes for use as radiopharmaceuticals
JP2860157B2 (ja) * 1990-10-31 1999-02-24 日本メジフィジックス株式会社 腎機能測定用の既放射能標識テクネチウムキレート注射剤の製造方法
EP0485664A1 (de) * 1990-11-13 1992-05-20 Mallinckrodt Diagnostica (Holland) B.V. Verfahren zur Herstellung von einem diagnostischen Mittel zur Feststellung von Entzündungen
CA2101642A1 (en) * 1991-02-14 1992-08-15 Alfons M. Verbruggen In situ synthesis of radiopharmaceuticals
AU1995392A (en) * 1991-05-08 1992-12-21 Mallinckrodt Medical, Inc. Technetium chelates to be used for determining the renal function
US5808091A (en) 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
EP0542216A1 (de) * 1991-11-13 1993-05-19 Hoechst Aktiengesellschaft Diaminomercapto (thio)ether als Komplexbildner für in der Nuklearmedizin einsetzbare Nuklide, Verfahren zur Herstellung der Komplexe, sowie Markierungskits, enthaltend diese Komplexe
US5738838A (en) * 1992-02-20 1998-04-14 Rhomed Incorporated IKVAV peptide radiopharmaceutical applications
DK0629133T3 (da) * 1992-01-03 2001-04-02 Rhomed Inc Farmaceutisk anvendelse af peptidmetalioner
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
US5688485A (en) * 1992-12-31 1997-11-18 The Dupont Merck Pharmaceutical Company Radiolabelled complexes of ester-substituted diaminethiols
DE4310999C2 (de) * 1993-03-31 1996-07-18 Diagnostikforschung Inst Bifunktionelle chalkogenatom-unterbrochene Chelatbildner vom Typ XN¶1¶S¶1¶X' für radioaktive Isotope und deren Metallkomplexe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel
DE4311022C2 (de) * 1993-03-31 1996-07-11 Diagnostikforschung Inst Bifunktionelle chalkogenatom-unterbrochene Chelatbildner vom Typ S¶3¶N¶2¶ für radioaktive Isotope und deren Metallkomplexe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel
DE4311023C2 (de) * 1993-03-31 1996-05-02 Diagnostikforschung Inst Bifunktionelle chalkogenatom-unterbrochene Chelatbildner von Typ XN¶1¶S¶1¶O¶1¶ für radioaktive Isotope, deren Metallkomplexe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel
US5464934A (en) * 1993-05-14 1995-11-07 Mallinckrodt Medical, Inc. Metal chelates as spacer compounds in biologically active peptides
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
JPH09500140A (ja) * 1993-07-19 1997-01-07 レゾリューション・ファーマスーティカルズ・インコーポレーテッド Ｎ▲下３▼ｓ立体配置を有するヒドラジノ型放射性核種キレート形成剤
US5858327A (en) * 1993-09-03 1999-01-12 Resolutions Pharmaceuticals, Inc. Hydrazino-type N2 S2 radionuclide chelating compounds
US5574140A (en) * 1993-09-03 1996-11-12 Resolution Pharmaceutical Inc. Hydrazino-type N2 S2 chelators
DE4425781A1 (de) * 1994-07-14 1996-01-18 Schering Ag Technetium-Sulfonamid-Komplexe, deren Verwendung, diese enthaltende pharmazeutische Mittel, sowie Verfahren zur Herstellung der Komplexe und Mittel
US5662885A (en) * 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
WO1996007629A1 (en) * 1994-09-08 1996-03-14 Mallinckrodt Medical, Inc. Technetium chelates to be used for determining the renal function
US5955053A (en) * 1996-05-06 1999-09-21 Emory University Metal chelates as pharmaceutical imaging agents, processes of making such and uses thereof
US5986074A (en) * 1996-05-06 1999-11-16 Emory University Metal chelates as pharmaceutical imaging agents, processes of making such and uses thereof
DE19860289C2 (de) * 1998-12-21 2003-11-13 Schering Ag Neue Chelatoren sowie deren Tricarbonyl-Komplexe mit Technetium und Rhenium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980147A (en) * 1984-06-25 1990-12-25 University Of Utah Research Foundation Radiolabeled technetium chelates for use in renal function determinations

Also Published As

Publication number Publication date
EP0250013A1 (de) 1987-12-23
CA1316296C (en) 1993-04-13
AU7360587A (en) 1988-12-01
US4849511A (en) 1989-07-18
EP0250013B1 (de) 1990-05-09
JPS62289596A (ja) 1987-12-16
ES2017088B3 (es) 1991-01-01
AU611854B2 (en) 1991-06-27
DE3762624D1 (de) 1990-06-13

Similar Documents

Publication Publication Date Title
ATE52516T1 (de) Technetiumchelate fuer die bestimmung der nierenfunktion.
ATE167188T1 (de) Technetium-99m-komplex zur untersuchung der nierenfunktion
ATE33634T1 (de) 1-methylamino-cyclopropan-1-carbonsaeure-derivat .
FI965020A (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
ES396223A1 (es) Un procedimiento para la produccion de nuevas n-fosfonome- til-glicinas.
CY1113359T1 (el) Αντι-νεοπλασιακα παραγωγα του et-743
FI971227A (fi) Pyramidinyylipyratsolijohdannaisia
HUP0202514A2 (hu) Antibakteriális szerek
JPS57134485A (en) Trisubstituted pyrimidopyrimidine
SE7411312L (de)
DE3572816D1 (de) Pyridazinone inotropic agents
ATE115534T1 (de) Substituierte beta-diketone.
ES437150A1 (es) Procedimiento para la produccion de derivados de xantina.
TR200002851T2 (tr) MRP1'i inhibe etmek için yöntemler.
GR3006821T3 (de)
ES440030A1 (es) Un procedimiento para preparar nuevos derivados de 2-ami- noindano.
ES389360A1 (es) Procedimiento para la preparacion de acidos ariloxi- o bienariltioalcanicos.
ES544919A0 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalcoholes
MY101173A (en) Non-radioactive biological probes.
ES531164A0 (es) Procedimiento para la preparacion de derivados de pirimidin-tioalquilpiridina
DK360286A (da) Substituerede phenylpiperazinderivater
JPS55379A (en) Biss*2*44dinitrophenyl**methyllpyridinium compound*its manufacture and ph determinating agent containing it
SE7714525L (sv) Sett att framstella n-substituerade 2-aminocyklopent-1-en-1-ditiokarboxylsyror
ES388284A1 (es) Procedimiento para la preparacion de derivados del s-dioxi-do de 3,4-dihidro-2h-1,2-benzotiacina.
ES324379A1 (es) Un metodo para la preparacion de derivados basicos de ftalanos e isocromanos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee